Relay Therapeutics (RLAY) Gains from Investment Securities (2020 - 2025)

Relay Therapeutics (RLAY) has disclosed Gains from Investment Securities for 5 consecutive years, with -$7.9 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities changed N/A to -$7.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$12.5 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.5 million for FY2023, N/A changed from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$7.9 million at Relay Therapeutics, down from $1.5 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $1.5 million in Q1 2023, with the low at -$7.9 million in Q4 2025.
  • Average Gains from Investment Securities over 4 years is -$750674.3, with a median of $1.5 million recorded in 2023.
  • The sharpest move saw Gains from Investment Securities plummeted 79.15% in 2021, then surged 132.92% in 2023.
  • Over 4 years, Gains from Investment Securities stood at $1.2 million in 2021, then crashed by 482.92% to -$4.6 million in 2022, then soared by 132.92% to $1.5 million in 2023, then plummeted by 622.93% to -$7.9 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$7.9 million, $1.5 million, and $1.5 million for Q4 2025, Q4 2023, and Q3 2023 respectively.